EFFICIENCY OF THE ENDOSOPIC CORRECTION OF HIGH-GRADE VESICOURETERAL REFLUX IN CHILDREN

S. N. Zorkin , D. S. Shakhnovsky , F. O. Turov , A. T. Galuzinskaya , E. Yu. Dyakonova

Russian Journal of Pediatric Surgery ›› 2020, Vol. 24 ›› Issue (5) : 292 -296.

PDF
Russian Journal of Pediatric Surgery ›› 2020, Vol. 24 ›› Issue (5) :292 -296. DOI: 10.18821/1560-9510-2020-24-5-292-296
ORIGINAL ARTICLES
other

EFFICIENCY OF THE ENDOSOPIC CORRECTION OF HIGH-GRADE VESICOURETERAL REFLUX IN CHILDREN

Author information +
History +
PDF

Abstract

Introduction. The endoscopic correction of vesicoureteral reflux in children has become a basic treatment technique. Its effectiveness in the low-grade reflux is high. High-grade refluxes are an indication for antireflux reconstructive plastic surgery. The article analyzes outomes of endoscopic treatment of patients with high-grade retrograde urine reflux. Material and methods. A total number of 307 patients (409 ureters) with IV-V grade of vesicoureteral reflux were treated. 156 girls and 151 boys, aged 4 months - 12 years, had the endoscopic correction with Dextranomer and Copolymer of Polyacrylic Polyvinyl Alcohol (PPC). The renal parenchyma damage was assessed with DMSA scan; urinary tract infection - with clinical and laboratory findings (febrile temperature and bacteriuria). Outcomes of treatment were evaluated with micurating cystography performed six months later. It revealed either no reflux or its lower grade - grade one. Average follow-up period was 5. 5 years. Results. The effectiveness of endoscopic correction of vesicoureteral reflux after the first injection was 68.7%. The second injection was effective in 48.9%. Febrile urinary tract infection after the treatment went down up to 6.2%. Marked bacteriuria remained high - 55.3%. Renal parenchyma structural and functional damage was noted in 38.9% of older children; mild and moderate degrees of damage prevailed (45.6% and 40.8%, respectively). Conclusion. The endoscopic correction of high-grade vesicoureteral reflux is recommended as the first line treatment for retrograde urine reflux. This technique is highly effective and minimally invasive.

Keywords

vesicoureteral reflux / endoscopic correction / children

Cite this article

Download citation ▾
S. N. Zorkin, D. S. Shakhnovsky, F. O. Turov, A. T. Galuzinskaya, E. Yu. Dyakonova. EFFICIENCY OF THE ENDOSOPIC CORRECTION OF HIGH-GRADE VESICOURETERAL REFLUX IN CHILDREN. Russian Journal of Pediatric Surgery, 2020, 24(5): 292-296 DOI:10.18821/1560-9510-2020-24-5-292-296

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Williams G., Fletcher J.T., Alexander S.I. et al. Vesicoureteral reflux. J Am Soc Nephrol. 2008;19:847.

[2]

Sargent M.A. What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol. 2000; 30: 587.

[3]

Swerkersson S., Jodal U., Sixt R. et al. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children. J Urol. 2007; 178:647.

[4]

Peters C., Rushton H.G. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol. 2010; 184: 265.

[5]

Brandstrom P., Neveus T., Sixt R. et al. The Swedish reflux trial in children: IV. Renal damage. J Urol. 2010; 184:292.

[6]

Routh J.C., Inman B.A., Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics. 2010; 125:1010.

[7]

Sjostrom S. Sillen U., Jodal U. et al. Predictive factors for resolution of congenital high grade vesicoureteral reflux in infants: results of univariate and multivariate analyses. J Urol. 2010; 183:1177.

[8]

Traxel E., DeFoor W., Reddy P. et al. Risk factors for urinary tract infection after dextranomer/hyaluronic acid endoscopic injection. J Urol. 2009; 182:1708.

[9]

Diamond D.A., Mattoo T.K. Endoscopic treatment of primary vesicoureteral reflux. N Engl J Med. 2012; 366: 1218.

[10]

Capozza N., Lais A., Matarazzo E. et al. Treatment of vesico-ureteric reflux: a new algorithm based on parental preference. BJU Int. 2003; 92:285.

[11]

Барсегян Е.Р., Зоркин С.Н. Сравнительная оценка результативности различных полимеров при эндоскопической коррекции пузырно-мочеточникового рефлюкса у детей. Детская хирургия. 2014; 5: 4-8.

[12]

Хворостов И.Н., Смирнов И.Е., Кучеренко А.Г., Герасимова Н.П., Комарова О.В., Зоркин С.Н. Нефросцинтиграфия и цитокины в диагностике поражения почек при пузырно-мочеточниковом рефлюксе у детей. Российский педиатрический журнал. 2013; 2:20-6.

[13]

Клиническая оценка расстройств мочеиспускания. Под ред. Е.Л. Вишневский, О.Б. Лоран, А.Е. Вишневский. М.: Терра, 2001.

[14]

Kirsch A.J., Perez-Brayfield M.R., Scherz H.C. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children’s Hospitals of Atlanta experience. J Urol. 2003; 170:211

[15]

Зоркин С.Н., Борисова С.А. Эндоскопическая коррекция пузырно-мочеточникового рефлюкса у детей. Лечащий Врач. 2013; 1: 42-4

[16]

Ogan K., Pohl H.G., Carlson D. et al. Parental preferences in the management of vesicoureteral reflux. J Urol. 2001; 166:240.

[17]

Hensle T.W., Grogg A.L., Eaddy M. Pediatric vesicoureteral reflux: treatment patterns and outcomes. Nat Clin Pract Urol. 2007; 4:462.

[18]

Peters C.A., Skoog S.J., Arant B.S. Jr et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol. 2010; 184: 1134.

[19]

Elder J.S., Shah M.B., Batiste L.R. et al. Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux. Curr Med Res Opin. 2007; 23: 15.

[20]

Chertin B., Natsheh A., Fridmans A. et al. Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux. J Urol. 2009; 182:1703.

[21]

Hunziker M., Colhoun E., Puri P. Prevalence and predictors of renal functional abnormalities of high grade vesicoureteral reflux. J Urol. 2013; 190:1490.

[22]

Cara-Fuentes G., Gupta N., Garin E.H. The RIVUR study: a review of its findings. Pediatr Nephrol. 2015; 30:703.

[23]

Medical versus surgical treatment of primary vesicoureteral reflux: report of the International Reflux Study Committee. Pediatrics. 1981; 67:392.

[24]

Schwab C.W. Jr, Wu H.Y., Selman H. et al. Spontaneous resolution of vesicoureteral reflux: a 15-year perspective. J Urol. 2002; 168:2594.

[25]

Elder J.S., Diaz M., Caldamone A.A. et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol. 2006; 175:716.

[26]

Elder J.S., Peters C.A., Arant B.S. Jr. et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol. 1997; 157:1846.

[27]

Holmdahl G., Brandstrom P., Lackgren G. et al. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. J Urol. 2010; 184:280.

[28]

Elmore J.M., Kirsch A.J., Heiss E.A. et al. Incidence of urinary tract infections in children after successful ureteral reimplantation versus endoscopic dextranomer/hyaluronic acid implantation. J Urol. 2008; 179:2364.

AI Summary AI Mindmap
PDF

58

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/